PL-2.3 How to outfox Big Pharma: Providing the best diabetes therapies to our patients at a lower cost to society

Jean-Fran├žois Yale, Canada

Professor of Endocrinology
Medecine
McGill University

Objectives

At the conclusion of this session, participants will be able to:

  • Discuss the place of SGLT2i and GLP-1 RA in the treatment of type 2 diabetes as per national and international guidelines
  • Implement strategies to offer thesetherapies without significantly increasingthe cost to society
  • Further reduce the cost of therapy bypromoting the judicious use of capillaryglucose strips

Questions Submitted

There are no questions yet...

If you have any questions, please consult our Help Desk.
© 2023 McGill Family Physician Refresher Course